New studies suggest that SGLT2 inhibitors, a class of diabetes drugs, may have heart-protective benefits beyond just controlling blood sugar levels. Researchers found that the drug can reduce the risk of heart failure and cardiovascular death in patients with and without diabetes. The findings were presented at the American College of Cardiology’s 70th Annual Scientific Session about heart health.

In other news, a study showed that adhering to a heart-healthy Mediterranean diet may lower the risk of heart disease, stroke, and cardiovascular death. The study involved over 25,000 adults in the U.S. and found that those who followed a Mediterranean-style diet had a 25% lower risk of cardiovascular disease compared to those who did not.

Additionally, a new study found that replacing red meat with plant-based proteins may lower the risk of heart disease. Researchers found that consuming plant-based proteins such as nuts, legumes, and soy instead of red meat led to lower levels of cholesterol and blood pressure, both of which are risk factors for heart disease.

Overall, these studies emphasize the importance of maintaining a healthy lifestyle to reduce the risk of heart disease and promote heart health.

Read more: https://www.healio.com/news/cardiology/20230501/top-news-of-april-updates-on-sglt2-inhibitors-heart-healthy-diets-and-more